Production (Stage)
Capha Pharmaceuticals Inc.
FPSUF
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.80K | 37.10K | 41.30K | 42.90K | 41.50K |
| Depreciation & Amortization | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.80K | 37.20K | 41.40K | 43.10K | 41.70K |
| Operating Income | -33.80K | -37.20K | -41.40K | -43.10K | -41.70K |
| Income Before Tax | -46.50K | -51.60K | -52.00K | -55.40K | -51.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.50K | -51.60K | -52.00K | -55.40K | -51.60K |
| EBIT | -33.80K | -37.20K | -41.40K | -43.10K | -41.70K |
| EBITDA | -33.80K | -37.10K | -41.30K | -42.90K | -41.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 257.72M | 257.72M | 257.72M | 257.72M | 257.72M |
| Average Diluted Shares Outstanding | 257.72M | 257.72M | 257.72M | 257.72M | 257.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |